Business Development & Operations

We work with pharmaceutical, biotech and medtech companies to bring their trials to Singapore, and help them navigate the clinical, regulatory and operational landscape here. From first enquiry to trial start-up, we make the path clearer.

Our activities span the practical and the strategic:

• Running talks for the innovation community — sessions led by subject matter experts, opening up the science, regulation and practice behind clinical research

• Conducting regional study visits — hosting delegations here and visiting partners across the region, exchanging first-hand views of clinical research capabilities, practice and opportunities

• Participating in process improvement with ecosystem partners — working alongside regulators, healthcare clusters and agencies to synergise new research opportunities and collaborations

• Hosting one-on-one sponsor consultations — direct guidance on navigating the clinical trial and innovation pathway, tailored to your study and stage

Whatever brings you to us, the conversation starts the same way: tell us what you are trying to do, and we will point you to the right people and the right route.

We support investigators who want to take an idea further — connecting them with industry partners or supporting their research for a better clinical outcome. Our aim is to help good research questions become well-run trials.

Our work with clinicians is deliberately personal:

• Meeting the clinicians on the ground — direct conversations with SCRI management, where an investigator can talk through an idea, a challenge or a possibility without a formal process getting in the way

• Listening to experienced and emerging investigators — gathering survey feedback on their research interests and the obstacles they face, so that our support reflects what clinicians actually need on the ground

• Partnering institutional research offices — working alongside research offices across our healthcare clusters to synergise research collaborations for their clinical investigators

• Pathing the way for research and operational support, big and small — from study design advice and protocol input to operational backing for multi-site trials, scaled to what the study calls for

A research question can start small. If you have an idea worth pursuing, we would like to hear it.

We extend Singapore's clinical research reach across southeast asia and beyond, building the networks and partnerships that make multi-country studies possible. Where a trial needs scale, the region gives it depth.

Scaling a study is an ongoing effort and it takes several forms:

• Collaborative MOUs across the region — formal partnerships with institutions and organisations to explore collaborative models

• Clinician-driven research and registry networks — supporting investigator-led networks and registries that generate evidence relevant to Asian patients and health systems, together with our Clinical Research Networks and Programme Management teams

• Trial collaboratives with clinical institutions — working with hospitals and research centres across the region to enable multi-site, multi-country studies possible

• Regional capability-building — creating opportunities to mutually share expertise and best practices so partners across the region can conduct and lead research to the same benchmarks

For sponsors, this means access to patient populations and clinical expertise beyond Singapore. For our regional partners, it means a collaborator invested in building capability, not just recruiting sites.